Article

Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.

Department of Pathology, Otto-von-Guericke-University, Leipziger Str. 44, D-39120 Magdeburg, Germany.
Journal of Clinical Pathology (Impact Factor: 2.55). 11/2005; 58(10):1069-75. DOI: 10.1136/jcp.2005.026328
Source: PubMed

ABSTRACT Aminopeptidase N (CD13) is expressed in normal and neoplastic liver tissue, where it exhibits a characteristic canalicular pattern (CD13(can)), similar to that seen for CD10 and when antibodies crossreact with biliary glycoprotein I (p-CEA).
To compare the putative diagnostic use of CD13(can) in differentiating between hepatocellular (HCC) and non-hepatocellular carcinomas metastatic to the liver (non-HCC).
A retrospective study comparing 53 HCC specimens with 32 non-HCC specimens. Immunostaining was performed with HepPar1 and antibodies directed against CD10, CD13, p-CEA, and alpha fetoprotein (AFP).
In the HCC group, a canalicular staining pattern was found for CD13, p-CEA, and CD10 in 51, 43, and 33 specimens, respectively. HepPar1 was positive in 29 and AFP in 17 HCC specimens. In the non-HCC group, canalicular immunostaining for CD10 and p-CEA was confined to non-neoplastic liver tissue. One poorly differentiated cholangiocarcinoma showed apical expression of CD13, resembling to some extent CD13(can). Sensitivity and specificity were 96.2% and 97.0%, respectively, for CD13(can), 81.1% and 100% for p-CEA(can), 62.3% and 100%, for CD10(can), 54.7% and 99.9% for HepPar1, and 32.1% and 100% for AFP.
These results show that CD13(can) is more sensitive in differentiating between HCC and non-HCC than CD10(can), p-CEA(can), HepPar1, and AFP.

0 Bookmarks
 · 
106 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Extremely low summer sea-ice coverage in the Arctic Ocean in 2007 allowed extensive sampling and a wide quasi-synoptic hydrographic and δ18O dataset could be collected in the Eurasian Basin and the Makarov Basin up to the Alpha Ridge and the East Siberian continental margin. With the aim of determining the origin of freshwater in the halocline, fractions of river water and sea-ice meltwater in the upper 150m were quantified by a combination of salinity and δ18O in the Eurasian Basin. Two methods, applying the preformed phosphate concentration (PO*) and the nitrate-to-phosphate ratio (N/P), were compared to further differentiate the marine fraction into Atlantic and Pacific-derived contributions. While PO*-based assessments systematically underestimate the contribution of Pacific-derived waters, N/P-based calculations overestimate Pacific-derived waters within the Transpolar Drift due to denitrification in bottom sediments at the Laptev Sea continental margin.Within the Eurasian Basin a west to east oriented front between net melting and production of sea-ice is observed. Outside the Atlantic regime dominated by net sea-ice melting, a pronounced layer influenced by brines released during sea-ice formation is present at about 30–50 m water depth with a maximum over the Lomonosov Ridge. The geographically distinct definition of this maximum demonstrates the rapid release and transport of signals from the shelf regions in discrete pulses within the Transpolar Drift.The ratio of sea-ice derived brine influence and river water is roughly constant within each layer of the Arctic Ocean halocline. The correlation between brine influence and river water reveals two clusters that can be assigned to the two main mechanisms of sea-ice formation within the Arctic Ocean. Over the open ocean or in polynyas at the continental slope where relatively small amounts of river water are found, sea-ice formation results in a linear correlation between brine influence and river water at salinities of about 32–34. In coastal polynyas in the shallow regions of the Laptev Sea and southern Kara Sea, sea-ice formation transports river water into the shelf’s bottom layer due to the close proximity to the river mouths. This process therefore results in waters that form a second linear correlation between brine influence and river water at salinities of about 30–32. Our study indicates which layers of the Arctic Ocean halocline are primarily influenced by sea-ice formation in coastal polynyas and which layers are primarily influenced by sea-ice formation over the open ocean. Accordingly we use the ratio of sea-ice derived brine influence and river water to link the maximum in brine influence within the Transpolar Drift with a pulse of shelf waters from the Laptev Sea that was likely released in summer 2005.
    Progress In Oceanography 12/2011; 91(4):482-495. DOI:10.1016/j.pocean.2011.07.017 · 3.99 Impact Factor
  • Viszeralchirurgie 08/2007; 42(4):215-222. DOI:10.1055/s-2007-981232 · 0.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Intrahepatic clear cell bile duct adenoma is extremely rare, with only 3 previous cases reported in the literature. The cause of cytoplasmic clearing in clear cell bile duct adenoma has not been previously investigated. Distinguishing clear cell bile duct adenoma from other clear cell tumors, particularly clear cell cholangiocarcinoma, can be challenging. Previous studies have shown loss of CD10 expression and focal CD56 expression in cholangiocarcinoma. Expressions of CD10 and CD56 have not been previously studied in clear cell bile duct adenoma. A 37-year-old morbidly obese woman was diagnosed with a 2.8 cm intrahepatic clear cell bile duct adenoma following segmental hepatic resection. Histochemical analysis of the tumor suggested the cause of cytoplasmic clearing in the neoplastic cells to be mucin and not glycogen or lipid. On immunohistochemical staining, the neoplastic cells demonstrated staining for CK7, CA 19-9, polyclonal CEA, CD10 (apical), CD56 (focal), and vimentin. Ki-67 highlighted less than 2% of tumor cell nuclei. This is the first report to study the etiology of cell clearing in clear cell bile duct adenoma. Expression of CD10 in clear cell bile duct adenoma may help distinguish clear cell bile duct adenoma from clear cell cholangiocarcinoma.
    01/2014; 2014:874826. DOI:10.1155/2014/874826

Full-text (2 Sources)

Download
28 Downloads
Available from
May 31, 2014